Olanzapine (zyprexa) in combination with fluoxetine (prozac), lithium or anticonvulsant for therapy of refractory depression

• 1. 一种奥氮平氟西汀复方胶囊制剂及其制备方法 [P] . 中国专利： CN111643506B . 2021.05.04
• 2. 一种奥氮平盐酸氟西汀复方制剂及其制备方法 [P] . 中国专利： CN111388480A . 2020-07-10
• 3. Olanzapine (zyprexa) in combination with fluoxetine (prozac), lithium or anticonvulsant for therapy of refractory depression [P] . 欧洲知识产权局专利： EP0958824A3 . 1999-12-01

  机译： 奥氮平（zyprexa）与氟西汀（百忧解），锂或抗惊厥药联合治疗难治性抑郁症

• 4. Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder [P] . 欧洲知识产权局专利： EP0966967A3 . 2000-05-31

  机译： 奥氮平（zyprexa）和氟西汀（prozac）的联合治疗双相情感障碍

• 5. Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder [P] . 欧洲知识产权局专利： EP0966967A2 . 1999-12-29

  机译： 奥氮平（zyprexa）和氟西汀（prozac）的联合治疗双相情感障碍

• 1. Sequential Combination Diuretic-Therapy for Massive Fluid Overload in Furosemide-Refractory Patients with Diabetic Kidney Disease [J] . Kamel El-Reshaid, Shaikha Al-Bader 肾脏病（英文） . 2021,第002期
• 2. Combination of CRISPR/Cas9 System and CAR-T Cell Therapy:A New Era for Refractory and Relapsed Hematological Malignancies [J] . Ke-jia HU, Elaine Tan Su YIN, Yong-xian HU, 当代医学科学(英文) . 2021,第003期
• 3. The efficacy of three treatments for depression: Morita psychotherapy, dietary brain -chemistry treatment, and the combination of Morita psychotherapy/brain-chemistry treatment as compared to no-treatment control. [D] . Hanson, Lynn M. 2002
• 4. Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy safety and study design issues [O] . William V Bobo, Richard C Shelton 2009
• 5. Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues [O] . Bobo, William V, Shelton, Richard C 2009

• 1. GENOTOXIC EFFECTS IN EPILEPTIC PATIENTS ON COMBINATIONS OF ANTICONVULSANT THERAPY [J] . Shobha Goyle ,Professor School of Life Sciences ,Jawaharlal Nehru University . 癌变．畸变．突变 . 1991,第0S1期
• 2. Combination of CRISPR/Cas9 System and CAR-T Cell Therapy:A New Era for Refractory and Relapsed Hematological Malignancies [J] . Ke-jia HU ,Elaine Tan Su YIN ,Yong-xian HU . 华中科技大学学报（医学）（英德文版） . 2021,第003期
• 3. Epirubicin,Cisplatin,5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma [J] . Ji Eun Lee ,Si Hyun Bae ,Jong Young Choi . 世界胃肠病学杂志：英文版 . 2014,第1期
• 4. 奥氮平对难治性抑郁症的疗效及认知功能的影响 [C] . 孙群星 ,龙金亮 ,朱玉星 . 2010年河南省精神病学学术会议 . 2010
• 5. 测定人血浆中奥氮平、氟西汀和诺氟西汀的Online SPE-LC-MS/MS方法的建立及其在治疗药物监测中的应用 [A] . 范怡然 . 2015